Medicines
New Gen
Automatic production of personalized medicines through pharmaceutical 3D printing
Improved healthcare for patients
Every patient is different
Every medication should be different
With over 8 years of expertise in pharmaceutical 3D printing, MB Therapeutics, a company based in Montpellier, France, offers a solution for manufacturing personalized medicine through healthcare 3D printing.
A patient centric solution
We offer a patient-centric solution to develop and produce personalized medicines through 3D printing, allowing dosage customization, customized forms, and the ability to combine multiple active ingredients within a single medication.
Is my molecule printable?
Let’s discuss its printability!
By discussing its physicochemical properties, we can provide you with an evaluation of its printability and determine which pharmaceutical 3D printing technology is best suited for it.
Innovation serving patients
We offer a patient-centered solution to develop and produce personalized medicines through pharmaceutical 3D printing, allowing dosage customization, customized forms, and the combination of multiple active ingredients within a medication.
Pharmaceutical industry
Improving time to market with a more flexible solution and adaptable clinical trials.
Innovation
Developing the solutions of tomorrow through a technology that incorporates multiple 3D printing technologies.
Testimonials
3D printing of medicines: MB Therapeutics at the BioTrace congress
Discover 3D printing of medications and how it is transforming pharmaceutical production, particularly with 3DforPedia.
MB Therapeutics: 3D printing at the heart of regional innovation
Focus on 3D printing: MB Therapeutics welcomes long-standing partners University of Montpellier, Nîmes University Hospital, and the Occitanie Region.
MB Therapeutics awarded France 2030 project grant: accelerating innovation in healthcare
€500,000 to industrialize our pharmaceutical inks and equip the first pilot pharmacies by 2026. Discover how this strategic support will accelerate our deployment.
MB Therapeutics strengthens its growth strategy with the appointment of a Chief Business Officer
Meet our Chief Business Officer, appointed to accelerate our commercial development and expand our model internationally.
Our partners
